An Attempt at Selective Protection from Phenoxybenzamine of Postjunctional Alpha-adrenoceptor Subtypes Mediating Contractions to Noradrenaline in the Rabbit Isolated Saphenous Vein
Overview
Authors
Affiliations
1. An attempt has been made, with the irreversible alpha-adrenoceptor antagonist phenoxybenzamine, to find the conditions under which postjunctional alpha 1-adrenoceptors in the rabbit isolated saphenous vein can be inactivated, such that postjunctional alpha 2-adrenoceptors can be studied in isolation. 2. Following exposure to various concentrations of phenoxybenzamine, no evidence was found for a selective inactivation of the postjunctional population of alpha 1-adrenoceptors: the "rauwolscine-resistant' (alpha 1-) and the "rauwolscine-sensitive' (alpha 2-) responses to (--)-noradrenaline were similarly affected. 3. However, in "receptor protection' experiments following exposure to a combination of phenoxybenzamine and the selective alpha 2-adrenoceptor antagonist rauwolscine, the remaining response to (--)-noradrenaline appeared to be mediated by a single population of postjunctional alpha 2-adrenoceptors: the response was insensitive to prazosin and rauwolscine was more potent than corynanthine. 4. Partial isolation of the alpha 1-adrenoceptor population was attempted by pre-exposure of the preparation to a combination of phenoxybenzamine and a selective alpha 1-adrenoceptor antagonist, i.e. prazosin or YM-12617. Following receptor protection, the inhibition produced by "selective' concentrations of either of these alpha 1-adrenoceptor antagonists were not significantly different from that observed in control preparations (no phenoxybenzamine). However, the selective alpha 2-adrenoceptor antagonists rauwolscine and CH-38083 were still able to inhibit part of the remaining responses to NA. This is interpreted as indicating that, in addition to protecting the putative postjunctional alpha 1-adrenoceptors, these procedures fail to produce complete inactivation of postjunctional alpha 2-adrenoceptors. 5. It is concluded that, although phenoxybenzamine appeared to be non-selective for the two populations of postjunctional alpha-adrenoceptors in the rabbit isolated saphenous vein, inclusion of a "selective' concentration of a competitive antagonist during the inactivation period results in differing degrees of functional protection of each subtype. Pharmacological isolation was possible for alpha 2-adrenoceptors but not convincingly for alpha 1-adrenoceptors.
Cohen M, Schenck K Br J Pharmacol. 2000; 131(3):562-8.
PMID: 11015308 PMC: 1572346. DOI: 10.1038/sj.bjp.0703587.
Reynen P, Martin G, Eglen R, MacLennan S Br J Pharmacol. 2000; 129(7):1339-46.
PMID: 10742289 PMC: 1571968. DOI: 10.1038/sj.bjp.0703184.
Blaylock N, Wilson V Br J Pharmacol. 1995; 114(3):694-702.
PMID: 7735696 PMC: 1510004. DOI: 10.1111/j.1476-5381.1995.tb17194.x.
Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts.
Br J Pharmacol. 1989; 98 Suppl:606P-773P.
PMID: 2775936 PMC: 1950871.
Dunn W, McGrath J, Wilson V Br J Pharmacol. 1989; 96(2):259-61.
PMID: 2564291 PMC: 1854344. DOI: 10.1111/j.1476-5381.1989.tb11810.x.